Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

810 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Textbook outcomes in liver surgery for gallbladder cancer patients treated with curative-intent resection: a multicenter observational study.
Liu ZP, Guo W, Yin DL, Chen WY, Wang JY, Li XL, Yue P, Yu C, Wu ZP, Ding R, Zhu Y, Huang F, Zhou JX, Zhang D, Chen W, Jiang Y, Bai J, Wang JJ, Zhang YQ, Dai HS, Lau WY, Chen ZY. Liu ZP, et al. Among authors: lau wy. Int J Surg. 2023 Sep 1;109(9):2751-2761. doi: 10.1097/JS9.0000000000000510. Int J Surg. 2023. PMID: 37288584 Free PMC article.
Impact of perioperative blood transfusion on long-term survival in patients with different stages of perihilar cholangiocarcinoma treated with curative resection: A multicentre propensity score matching study.
Liu ZP, Cheng ZJ, Dai HS, Zhong SY, Zhao DC, Gong Y, Zuo JH, Che XY, Chen WY, Wang ZR, Yu T, Cheng JJ, Liu XC, Bai J, Jiang Y, Zhang YQ, Lau WY, Deng SQ, Chen ZY. Liu ZP, et al. Among authors: lau wy. Front Oncol. 2022 Oct 31;12:1059581. doi: 10.3389/fonc.2022.1059581. eCollection 2022. Front Oncol. 2022. PMID: 36387093 Free PMC article.
Irradiation stent with 125 I plus TACE versus sorafenib plus TACE for hepatocellular carcinoma with major portal vein tumor thrombosis: a multicenter randomized trial.
Lu J, Guo JH, Ji JS, Li YL, Lv WF, Zhu HD, Sun JH, Ren WX, Zhang FJ, Wang WD, Shao HB, Cao GS, Li HL, Gao K, Yang P, Yin GW, Zhu GY, Wu FZ, Wang WJ, Lu D, Chen SQ, Min J, Zhao Y, Li R, Lu LG, Lau WY, Teng GJ. Lu J, et al. Among authors: lau wy. Int J Surg. 2023 May 1;109(5):1188-1198. doi: 10.1097/JS9.0000000000000295. Int J Surg. 2023. PMID: 37038986 Free PMC article. Clinical Trial.
Watch-and-wait strategy vs. resection in patients with radiologic complete response after conversion therapy for initially unresectable hepatocellular carcinoma: a propensity score-matching comparative study.
Li B, Wang C, He W, Qiu J, Zheng Y, Zou R, Lin Z, Shi Y, Yuan Y, Zhang R, Zhang C, Chen M, Lau WY, Yuan Y. Li B, et al. Among authors: lau wy. Int J Surg. 2024 May 1;110(5):2545-2555. doi: 10.1097/JS9.0000000000001155. Int J Surg. 2024. PMID: 38329081 Free PMC article.
Long-term prognosis of patients with gallbladder carcinoma after curative-intent resection based on changes in the ratio of carbohydrate antigen 19-9 to total bilirubin (CA19-9/TB): a multicenter retrospective cohort study.
Li XL, Liu ZP, Su XX, Gong Y, Yang YS, Zhao XL, Li ZM, Ding JJ, Zhu Y, Yin DL, Yu C, Zhou JX, Zhang D, Ding R, Chen W, Cheng Y, Yue P, Wang ZR, Zhang YQ, Jiang Y, Yin XY, Bai J, Dai HS, Lau WY, Chen ZY; Biliary Surgery Branch of Elite Group of Chinese Digestive Surgery (EGCDS). Li XL, et al. Among authors: lau wy. Int J Surg. 2024 Apr 17. doi: 10.1097/JS9.0000000000001379. Online ahead of print. Int J Surg. 2024. PMID: 38626431
Patterns, treatments, and prognosis of tumor recurrence after resection for hepatocellular carcinoma with microvascular invasion: a multicenter study from China.
Chen ZH, Zhang XP, Feng JK, Li LQ, Zhang F, Hu YR, Zhong CQ, Wang K, Chai ZT, Wei XB, Shi J, Guo WX, Wu MC, Lau WY, Cheng SQ. Chen ZH, et al. Among authors: lau wy. HPB (Oxford). 2022 Jul;24(7):1063-1073. doi: 10.1016/j.hpb.2021.11.016. Epub 2021 Dec 3. HPB (Oxford). 2022. PMID: 34961677 Free article.
Association of tumor morphology with long-term prognosis after liver resection for patients with a solitary huge hepatocellular carcinoma-a multicenter propensity score matching analysis.
Xu XF, Wu H, Li JD, Yao LQ, Huang B, Diao YK, Chen TH, Gu WM, Chen Z, Li J, Zhang YM, Wang H, Liang YJ, Zhou YH, Li C, Wang MD, Zhang CW, Pawlik TM, Lau WY, Shen F, Yang T. Xu XF, et al. Among authors: lau wy. Hepatobiliary Surg Nutr. 2023 Jun 1;12(3):314-327. doi: 10.21037/hbsn-21-423. Epub 2022 Feb 15. Hepatobiliary Surg Nutr. 2023. PMID: 37351131 Free PMC article.
810 results